#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	444	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1085	21.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	297	299	ACG	24;24;24	A;C;G	24;24;24	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	274	Chlamydophila_psittaci_16S	1507	100	95.0	Chlamydophila_psittaci_16S.l15.c4.ctg.3	131	24.7	0	.	n	.	0	G906T	SNP	906	906	G	7	7	T	14	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	274	Chlamydophila_psittaci_16S	1507	100	95.0	Chlamydophila_psittaci_16S.l15.c4.ctg.3	131	24.7	0	.	n	.	0	G908A	SNP	908	908	G	9	9	A	14	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	274	Chlamydophila_psittaci_16S	1507	100	95.0	Chlamydophila_psittaci_16S.l15.c4.ctg.3	131	24.7	0	.	n	.	0	A918T	SNP	918	918	A	19	19	T	26	T	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	274	Chlamydophila_psittaci_16S	1507	100	95.0	Chlamydophila_psittaci_16S.l15.c4.ctg.3	131	24.7	0	.	n	.	0	A943G	SNP	943	943	A	44	44	G	55	G	54	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	274	Chlamydophila_psittaci_16S	1507	100	95.0	Chlamydophila_psittaci_16S.l15.c4.ctg.3	131	24.7	0	.	n	.	0	G991T	SNP	991	991	G	92	92	T	25	T,C	24,1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	1210	99.42	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1403	64.1	1	SNP	p	R234F	1	.	.	700	702	TTC	893	895	TTC	82;82;81	T;T;C	82;82;81	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	1210	99.42	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1403	64.1	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1193	1195	CGT	83;82;82	C;G;T	82;82;81	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	1210	99.42	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1403	64.1	0	HET	.	.	.	T999C	.	999	999	T	1192	1192	T	80	T,C	49,30	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	1210	99.42	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1403	64.1	0	HET	.	.	.	T90C	.	90	90	T	283	283	T	34	T,C	21,13	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	1210	99.42	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1403	64.1	0	HET	.	.	.	C255T	.	255	255	C	448	448	C	74	C,T	37,37	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1836	Escherichia_coli_EF_Tu	1230	70	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.3	208	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	520	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c17.ctg.1	1704	16.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1522	1524	AAA	4;4;4	A;A;A	4;4;4	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	748	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1625	24.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1195	1197	GAA	25;26;26	G;A;A	25;26;26	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	140	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	479	12.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	586	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1323	23.1	0	.	p	.	0	H2R	NONSYN	4	6	CAT	200	202	CGT	18;19;20	C;G;T	18;19;20	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	586	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1323	23.1	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1043	1045	GGC	28;27;28	G;G;C	28;27;28	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1997	23.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	184	186	AGC	7;7;7	A;G;C	7;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1997	23.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	586	588	CTA	29;30;30	C;T;A	28;30;29	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1997	23.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1105	1107	CAA	39;38;39	C;A;A	39;38;39	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1997	23.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1204	1206	GGT	50;49;49	G;G;T,C	50;49;48,1	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1997	23.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1774	1776	GTT	17;17;15	G;T;T	17;17;15	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	316	PmrE	1167	490	98.78	PmrE.l15.c30.ctg.1	686	12.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	569	571	GAA	12;12;12	G;A;A	12;12;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	316	PmrE	1167	490	98.78	PmrE.l15.c30.ctg.1	686	12.9	0	.	p	.	0	I136N	NONSYN	406	408	ATT	602	604	AAT	9;8;8	A;A,T;T	9;0,8;8	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	316	PmrE	1167	612	95.75	PmrE.l15.c30.ctg.2	736	10.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	122	124	ACT	8;8;7	A;C;T	8;8;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	316	PmrE	1167	612	95.75	PmrE.l15.c30.ctg.2	736	10.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	512	514	ATC	9;9;9	A;T;C	9;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	412	PmrF	969	969	99.38	PmrF.l6.c4.ctg.1	1368	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	16	48	TEM_1+	858	202	100.0	TEM_1+.l15.c30.ctg.1	202	3.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1488	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3474	22.9	0	.	p	.	0	T85I	NONSYN	253	255	ACC	440	442	ATC	21;21;21	A;T;C	21;21;21	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1488	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3474	22.9	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2153	2155	AAG	13;16;16	A;A,G;G	13;15,1;16	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	748	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1561	25.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	253	255	GTC	9;8;10	G;T;C	9;8;10	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	748	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1561	25.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	994	996	TGC	47;48;51	T;G;C	47;48;51	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	S46trunc	TRUNC	136	136	T	337	337	T	16	T	15	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	G148D	NONSYN	442	444	GGC	643	645	GAC	23;21;22	G;A;C	22;21;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	F240L	NONSYN	718	720	TTT	919	921	TTA	23;22;22	T;T;A	23;22;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1996	1998	AAT	29;27;27	A;A;T	29;27;27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2110	2112	AGT	19;19;19	A;G;T	19;19;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2509	2511	GTG	22;21;20	G;T;G	22;21;20	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1752	acrF	3105	3105	98.78	acrF.l6.c17.ctg.1	3558	26.2	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3064	3066	AAG	29;30;30	A;A;G	29;30;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	308	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1048	15.7	1	SNP	p	R45C	0	.	.	133	135	CGC	317	319	CGC	26;26;26	C;G;C	26;26;26	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	354	acrS	663	663	98.79	acrS.l15.c30.ctg.1	810	21.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	161	163	TTC	18;20;21	T;T;C	18;20;21	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	354	acrS	663	663	98.79	acrS.l15.c30.ctg.1	810	21.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	425	427	GGG	20;20;20	G;G;G	20;20;20	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	426	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1084	20.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	538	540	CTT	29;32;31	C;T;T	29;32;31	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1532	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3024	27.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2058	2060	GCA	48;48;48	G;C;A	48;48;48	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1532	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3024	27.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2319	2321	ACC	26;26;26	A;C;C	26;26;26	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1532	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3024	27.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2628	2630	GCC	31;30;30	G;C;C	31;29;29	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	168	170	GCT	2;2;3	G;C;T	2;2;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	288	290	GAG	3;2;2	G;A;G	3;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	324	326	TGC	5;5;5	T;G;C	5;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	507	509	GTT	12;13;13	G;T;T	12;13;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	657	659	CAC	11;10;10	C;A;C	11;10;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	942	944	ATG	20;20;23	A;T;G	20;20;23	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	696	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2193	17.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1938	1940	CGC	18;18;18	C;G;C	18;18;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	344	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1023	17.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	853	855	ACC	9;9;9	A;C;C	9;9;9	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	344	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1023	17.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	865	867	TCG	7;8;9	T;C;G	7;8;9	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	260	baeR	723	723	97.79	baeR.l15.c4.ctg.1	945	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1583	15.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1299	1301	AAA	7;7;7	A;A;A	7;7;7	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1583	15.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1311	1313	GAG	6;7;6	G;A;G	6;5;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1583	15.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1317	1319	CAC	6;6;6	C;A;C	5;5;5	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1583	15.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1371	1373	GAG	17;17;17	G;A;G	17;17;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	826	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1723	25.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	468	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1080	23.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	358	cysB	975	975	99.38	cysB.l15.c30.ctg.1	1455	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	564	emrA	1173	1173	98.29	emrA.l15.c4.ctg.2	1215	23.0	0	.	p	.	0	W42C	NONSYN	124	126	TGG	150	152	TGT	12;12;10	T;G;T	12;11;10	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	564	emrA	1173	1173	98.29	emrA.l15.c4.ctg.2	1215	23.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	681	683	GTC	33;32;34	G;T;C	32;31;34	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	942	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	1891	26.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	618	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1656	20.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	814	816	AGC	19;19;19	A;G;C	19;19;19	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	380	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1445	14.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	718	720	AGG	6;6;6	A;G;G	5;6;6	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	380	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1445	14.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1108	1110	GAC	7;7;7	G;A;C	7;7;7	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	282	emrR	531	531	100.0	emrR.l6.c30.ctg.1	949	15.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	556	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1911	15.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	262	evgA	615	615	99.19	evgA.l6.c30.ctg.1	996	14.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	375	377	CTG	14;15;13	C;T;G	14;15;13	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	172	174	ATA	2;2;2	A;T;A	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	184	186	GTA	6;7;7	G;T;A	6;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	337	339	ACG	7;7;7	A;C;G	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	400	402	GAA	10;10;10	G;A;A	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	439	441	GCT	24;24;23	G;C;T	23;24;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	457	459	GAT	19;18;18	G;A;T	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	544	546	TCA	5;5;5	T;C;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	673	675	CAG	9;10;9	C;A;G	9;10;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	811	813	GTT	7;7;6	G;T;T	7;7;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	967	969	GAT	4;3;3	G;A;T	4;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1135	1137	AAT	7;7;7	A;A;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1156	1158	TTA	5;5;5	T;T;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1357	1359	AAA	7;7;7	A;A;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2092	2094	CAT	9;9;8	C;A;T	9;9;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2146	2148	CAT	16;16;16	C;A;T	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2164	2166	AGA	19;19;20	A;G;A	19;18;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2179	2181	AAT	21;21;23	A;A;T	21;21;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2326	2328	TCC	11;11;12	T;C;C	11;11;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2491	2493	ATT	23;23;22	A;T;T	23;23;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2512	2514	GAT	20;20;20	G;A;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2626	2628	GTT	24;25;24	G;T;T	24;25;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1126	evgS	3594	3594	97.55	evgS.l6.c30.ctg.1	3835	15.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	2911	2913	CAC	30;30;29	C;A;C	30;30;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1104	22.2	1	SNP	p	P64L	0	.	.	190	192	CCA	359	361	CCA	47;46;45	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1104	22.2	1	SNP	p	P64H	0	.	.	190	192	CCA	359	361	CCA	47;46;45	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1104	22.2	1	SNP	p	P64A	0	.	.	190	192	CCA	359	361	CCA	47;46;45	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1104	22.2	1	SNP	p	P64S	0	.	.	190	192	CCA	359	361	CCA	47;46;45	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	476	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1104	22.2	1	SNP	p	P64R	0	.	.	190	192	CCA	359	361	CCA	47;46;45	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	258	gadE	528	528	100.0	gadE.l15.c30.ctg.1	925	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	104	gadW	729	169	92.9	gadW.l15.c30.ctg.1	169	4.5	0	.	p	.	0	L46P	NONSYN	136	138	CTG	6	8	CCG	1;1;1	C;C;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	104	gadW	729	169	92.9	gadW.l15.c30.ctg.1	169	4.5	0	.	p	.	0	E54D	NONSYN	160	162	GAA	30	32	GAT	5;7;7	G;A;T	5;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	104	gadW	729	169	92.9	gadW.l15.c30.ctg.1	169	4.5	0	.	p	.	0	I88M	NONSYN	262	264	ATA	132	134	ATG	5;5;5	A;T;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	104	gadW	729	169	92.9	gadW.l15.c30.ctg.1	169	4.5	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	135	137	CCG	5;5;5	C;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	326	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1073	16.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	315	317	TTA	19;18;16	T;T;A	19;18;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	326	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1073	16.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	393	395	ATT	16;16;16	A;T;T	16;16;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	326	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1073	16.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	894	896	GGA	20;19;18	G;G;A	20;19;18	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	326	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1073	16.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	900	902	CCG	15;16;16	C;C;G	15;15;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2091	2093	GAA	20;19;19	G;A;A	20;19;19	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	S83W	0	.	.	247	249	TCG	306	308	TCG	24;25;24	T;C;G	24;24;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	S83L	0	.	.	247	249	TCG	306	308	TCG	24;25;24	T;C;G	24;24;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	S83I	0	.	.	247	249	TCG	306	308	TCG	24;25;24	T;C;G	24;24;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	D87H	0	.	.	259	261	GAC	318	320	GAC	21;22;21	G;A;C	21;21;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	D87V	0	.	.	259	261	GAC	318	320	GAC	21;22;21	G;A;C	21;21;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	D87Y	0	.	.	259	261	GAC	318	320	GAC	21;22;21	G;A;C	21;21;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	D87N	0	.	.	259	261	GAC	318	320	GAC	21;22;21	G;A;C	21;21;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1222	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2799	22.7	1	SNP	p	D87G	0	.	.	259	261	GAC	318	320	GAC	21;22;21	G;A;C	21;21;21	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136L	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136S	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136E	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136G	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136I	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136H	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1352	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2859	25.3	1	SNP	p	R136C	0	.	.	406	408	CGC	602	604	CGC	18;17;18	C;G;C	18;17;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	196	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1012	10.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	424	426	CCG	12;12;12	C;C;G	12;11;12	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	196	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1012	10.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	577	579	GCC	14;14;15	G;C;C	13;13;15	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	528	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1334	21.2	0	.	p	.	0	P9S	NONSYN	25	27	CCA	170	172	TCA	14;14;13	T;C;A	14;14;13	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	146	marA	384	384	99.74	marA.l15.c4.ctg.1	769	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	463	465	AGC	11;11;10	A;G;C	11;11;10	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	565	567	CAT	4;4;4	C;A;T	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	V45E	0	.	.	133	135	GTG	289	291	GTG	19;18;18	G;T;G	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	I49S	0	.	.	145	147	ATC	301	303	ATC	21;19;19	A;T;C	21;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	A70T	0	.	.	208	210	GCA	364	366	GCA	6;6;6	G;C;A	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R73S	0	.	.	217	219	CGT	373	375	CGT	6;6;6	C;G;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R73C	0	.	.	217	219	CGT	373	375	CGT	6;6;6	C;G;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R77C	0	.	.	229	231	CGC	385	387	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R77L	0	.	.	229	231	CGC	385	387	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	L78M	0	.	.	232	234	CTG	388	390	CTG	5;5;5	C;T;G	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R94H	0	.	.	280	282	CGC	436	438	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	R94S	0	.	.	280	282	CGC	436	438	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	110	marR	435	435	97.7	marR.l6.c30.ctg.1	659	8.3	1	SNP	p	V96E	0	.	.	286	288	GTA	442	444	GTA	11;11;11	G;T;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	19	21	TTC	2;2;2	T;T;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	106	108	ATC	8;8;8	A;T;C	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	124	126	GCC	1;1;1	G;C;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	127	129	GTG	1;1;1	G;T;G	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	154	156	GAT	5;5;5	G;A;T	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	175	177	ACC	5;5;6	A;C;C	5;5;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	202	204	TTA	12;12;11	T;T;A	11;12;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	340	mdfA	1233	1233	96.67	mdfA.l6.c4.ctg.1	1385	13.0	0	.	p	.	0	G88fs	FSHIFT	262	262	G	262	262	G	11	G	11	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	328	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1419	11.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	34	34	G	9	G	8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	328	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1419	11.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	91	93	CAG	7;8;6	C;A;G,A	7;8;5,1	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	328	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1419	11.8	0	.	p	.	0	T83I	NONSYN	247	249	ACC	241	243	ATC	5;5;4	A;T;C	5;5;4	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	328	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1419	11.8	0	.	p	.	0	I99M	NONSYN	295	297	ATA	289	291	ATG	3;4;4	A;T;G	3;4;4	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	328	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1419	11.8	0	.	p	.	0	A130T	NONSYN	388	390	GCC	382	384	ACC	8;7;8	A;C;C	8;7;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1950	1952	ACC	27;27;27	A;C;C	26;26;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2343	2345	CAA	15;16;14	C;A;A	15;16;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2511	2513	ATT	16;16;16	A;T;T	16;16;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2595	2597	GTT	17;17;17	G;T;T	17;17;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2703	2705	GAG	12;12;11	G;A;G	11;12;11	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2931	2933	ATG	12;13;13	A;T;G	11;13;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1294	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3422	20.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3066	3068	GAT	15;16;17	G;A;T	15;15;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	71	73	ATG	13;11;13	A;T;G	13;11;13	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	557	559	ATC	18;18;16	A;T;C	18;18;16	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	G972T	NONSYN	2914	2916	GGC	2849	2851	ACC	2;2;2	A;C;C	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	D974V	NONSYN	2920	2922	GAC	2855	2857	GTC	2;2;2	G;T;C	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	S976A	NONSYN	2926	2928	TCG	2861	2863	GCG	2;2;2	G;C;G	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	Q980R	NONSYN	2938	2940	CAA	2873	2875	CGT	2;2;2	C;G;T	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	T985G	NONSYN	2953	2955	ACC	2888	2890	GGC	2;2;2	G;G;C	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	I986M	NONSYN	2956	2958	ATT	2891	2893	ATG	2;2;2	A;T;G	2;2;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	V991I	NONSYN	2971	2973	GTA	2906	2908	ATT	4;4;4	A;T;T	4;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	M992V	NONSYN	2974	2976	ATG	2909	2911	GTC	4;4;4	G;T;C	4;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	L995V	NONSYN	2983	2985	CTC	2918	2920	GTG	7;7;7	G,C;T;G,T	6,1;7;6,1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	Y999F	NONSYN	2995	2997	TAT	2930	2932	TTC	11;11;11	T;T,A;C,T	11;9,2;9,2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	V1004I	NONSYN	3010	3012	GTG	2945	2947	ATT	14;14;14	A,G;T;T,G	12,2;14;12,2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1086	mdtC	3078	2968	97.68	mdtC.l15.c30.ctg.1	3065	18.7	0	.	p	.	0	F1007L	NONSYN	3019	3021	TTT	2954	2956	CTG	14;13;13	C,T;T;G,T	12,2;13;11,2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	492	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1645	15.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	38	40	GAA	14;14;14	G;A;A	14;14;14	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	492	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1645	15.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	707	709	GCG	25;25;25	G;C;G	25;25;25	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	492	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1645	15.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1049	1051	ATC	18;19;20	A;T;C	16;18;19	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	492	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1645	15.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1352	1354	TTT	22;22;26	T;T;T	22;22;26	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	790	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1525	27.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1860	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3454	28.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1060	1062	ACC	26;26;26	A;C,A;C	26;22,1;26	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1860	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3454	28.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2302	2304	GAC	32;33;33	G;A;C	32;32;33	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	524	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1465	14.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	610	612	ATC	14;14;15	A;T;C	14;14;15	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	524	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	573	10.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	198	200	GGA	13;14;15	G;G;A	13;14;14	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	408	mdtH	1209	1197	98.25	mdtH.l15.c4.ctg.2	1345	15.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	391	393	TGT	14;14;13	T;G;T	14;14;13	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	408	mdtH	1209	1197	98.25	mdtH.l15.c4.ctg.2	1345	15.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	961	963	TTG	21;22;21	T;T;G	21;22;21	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	408	mdtH	1209	1197	98.25	mdtH.l15.c4.ctg.2	1345	15.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1171	1173	ACG	6;6;6	A;C;G	6;6;6	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	531	662	mdtL	1176	1176	98.3	mdtL.l15.c30.ctg.1	1420	24.0	0	.	p	.	0	W161trunc	TRUNC	481	481	T	668	668	T	20	T	20	.	Multidrug resistance protein MdtL;mdtL
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	531	662	mdtL	1176	1176	98.3	mdtL.l15.c30.ctg.1	1420	24.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	740	742	TCC	22;23;23	T;C;C	22;23;23	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	428	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1413	16.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	548	550	ATT	13;12;13	A;T;T	13;12;13	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	178	180	ATG	14;13;14	A;T;G	14;13;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	244	246	ATC	9;9;9	A;T;C	8;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	493	495	CGC	29;31;31	C;G;C	28;31;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	859	861	AGC	27;26;25	A;G;C	27;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1060	1062	GTG	21;21;21	G;T;G	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1123	1125	AAC	6;5;5	A;A;C	4;3;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1168	1170	GTC	21;21;22	G;T;C	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1198	1200	ATA	30;30;30	A;T;A	28;29;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1306	1308	TCT	12;12;12	T;C;T	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1693	1695	GCG	21;21;20	G;C;G	21;20;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	962	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2486	20.8	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1906	1908	ATC	25;25;26	A;T;C	25;25;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	273	273	T	28	T	27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	S129A	NONSYN	385	387	TCA	456	458	GCG	19;20;21	G;C;G	19;19;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	A187T	NONSYN	559	561	GCC	630	632	ACC	15;16;16	A;C;C	15;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	H211R	NONSYN	631	633	CAC	702	704	CGC	21;22;22	C;G;C	21;21;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	V250A	NONSYN	748	750	GTT	819	821	GCT	16;16;16	G;C;T	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	R278K	NONSYN	832	834	AGA	903	905	AAA	19;19;19	A;A;A	18;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	921	923	CGA	23;23;21	C;G;A	23;23;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1086	1088	GCC	16;16;16	G;C;C	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1098	1100	GAT	13;14;13	G;A;T	13;14;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	600	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1634	19.1	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1515	1517	GCT	6;5;4	G;C;T	6;5;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1390	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3827	19.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1476	1478	AAG	8;8;8	A;A;G	8;8;8	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1390	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3827	19.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2553	2555	CTG	18;17;16	C;T;G	18;17;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	70	mgrB	144	144	100.0	mgrB.l15.c4.ctg.1	160	11.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	904	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2158	22.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1029	1031	AAC	30;29;29	A;A;C	30;27;29	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	904	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2158	22.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1575	1577	ATA	36;36;35	A;T;A	36;36;35	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	754	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1679	24.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1358	1360	GAT	35;33;32	G;A;T	35;33;32	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	754	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1679	24.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1361	1363	CTG	33;33;33	C;T;G	33;33;33	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	278	280	TGT	18;18;17	T;G;T	18;18;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	548	550	ACC	25;26;25	A;C;C	25;26;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	758	760	GAC	14;13;14	G;A;C	14;13;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	1	SNP	p	R15C	0	.	.	43	45	CGC	242	244	CGC	30;30;30	C;G;C	30;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	1	SNP	p	S33R	0	.	.	97	99	AGC	296	298	AGC	17;17;17	A;G;C,A	17;17;16,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	1	SNP	p	G131D	0	.	.	391	393	GGC	590	592	GGC	18;18;17	G;G;C	18;18;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	1	SNP	p	R203C	0	.	.	607	609	CGT	806	808	CGT	17;17;17	C;G;T	17;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1188	13.1	1	SNP	p	R203L	0	.	.	607	609	CGT	806	808	CGT	17;17;17	C;G;T	17;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1326	22.0	0	.	p	.	0	D312E	NONSYN	934	936	GAT	973	975	GAG	37;37;36	G;A;G	37;37;36	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1326	22.0	1	SNP	p	G141E	0	.	.	421	423	GGT	460	462	GGT	29;29;29	G;G;T	29;29;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1326	22.0	1	SNP	p	G141D	0	.	.	421	423	GGT	460	462	GGT	29;29;29	G;G;T	29;29;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1326	22.0	1	SNP	p	R154A	0	.	.	460	462	CGT	499	501	CGT	20;21;20	C;G;T	20;20;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1326	22.0	1	SNP	p	R154D	0	.	.	460	462	CGT	499	501	CGT	20;21;20	C;G;T	20;20;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1492	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2719	29.4	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1827	1829	TCG	31;31;32	T;C;G	31;31;32	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1492	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2719	29.4	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2442	2444	AAC	17;17;16	A;A;C	17;17;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1492	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2719	29.4	1	SNP	p	A85T	0	.	.	253	255	GCG	456	458	GCG	29;29;29	G;C;G	28;27;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1492	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2719	29.4	1	SNP	p	D111H	0	.	.	331	333	GAT	534	536	GAT	23;23;23	G;A;T	23;23;23	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1492	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2719	29.4	1	SNP	p	S129P	0	.	.	385	387	TCC	588	590	TCC	32;32;33	T;C;C	31;32;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	862	parE_1	1893	1893	97.43	parE_1.l15.c30.ctg.1	1993	21.2	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1285	1287	GCT	31;30;31	G;C;T	31;30;31	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	862	parE_1	1893	140	98.57	parE_1.l15.c30.ctg.2	371	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	796	patA	1380	1380	99.86	patA.l6.c30.ctg.1	1810	23.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1296	1298	GAT	26;26;25	G;A;T	26;26;25	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	V146F	0	.	.	436	438	GTT	616	618	GTT	32;33;33	G,T;T;T	31,1;33;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1717	1719	CAG	36;35;36	C;A;G	35;34;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1717	1719	CAG	36;35;36	C;A;G	35;34;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1756	1758	CAC	42;42;39	C;A;C	40;41;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1765	1767	CGT	34;34;34	C;G;T	34;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1765	1767	CGT	34;34;34	C;G;T	34;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1771	1773	TCC	28;28;27	T;C;C	28;28;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1777	1779	CTC	24;25;21	C;T;C	24;25;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1867	1869	ACC	39;39;39	A;C;C	39;39;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1870	1872	CCT	39;41;40	C;C;T	39;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2812	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4414	34.2	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2239	2241	CGT	61;59;57	C;G;T	60;59;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	.	n	.	0	A226G	SNP	226	226	A	332	332	G	220	G	220	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	1	SNP	n	A794G	0	.	.	794	794	A	900	900	A	170	A,C	166,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	1	SNP	n	A794T	0	.	.	794	794	A	900	900	A	170	A,C	166,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	1	SNP	n	G926C	0	.	.	926	926	G	1032	1032	G	184	G	184	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	1	SNP	n	G926T	0	.	.	926	926	G	1032	1032	G	184	G	184	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	1	SNP	n	G926A	0	.	.	926	926	G	1032	1032	G	184	G	184	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	C183T	.	183	183	C	289	289	C	172	C,T	110,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	T90C	.	90	90	T	196	196	T	180	T,C	147,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	A250T	.	250	250	A	356	356	A	209	A,T	162,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	G474A	.	474	474	G	580	580	G	215	G,A	162,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	A253T	.	253	253	A	359	359	A	202	A,T	155,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	C194T	.	194	194	C	300	300	C	191	C,T	150,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	C719T	.	719	719	C	825	825	C	176	C,T	103,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	A79G	.	79	79	A	185	185	A	187	A,G	149,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1107	181.6	0	HET	.	.	.	T273A	.	273	273	T	379	379	T	195	T,A	152,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	519	99.81	rrsB+.l15.c30.ctg.2	532	215.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	15	15	T	176	T,C	51,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	519	99.81	rrsB+.l15.c30.ctg.2	532	215.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	496	496	A	142	A	140	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	519	99.81	rrsB+.l15.c30.ctg.2	532	215.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	496	496	A	142	A	140	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	673	6392	rrsB+	1542	519	99.81	rrsB+.l15.c30.ctg.2	532	215.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	496	496	A	142	A	140	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	312	soxR	465	465	100.0	soxR.l15.c4.ctg.1	857	19.6	1	SNP	p	R20H	0	.	.	58	60	CGC	217	219	CGC	26;28;28	C;G;C	26;28;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	312	soxR	465	465	100.0	soxR.l15.c4.ctg.1	857	19.6	1	SNP	p	G121D	0	.	.	361	363	GGT	520	522	GGT	26;26;26	G;G;T	26;26;26	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	236	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	733	17.2	1	SNP	p	A12S	0	.	.	34	36	GCA	225	227	GCA	31;30;31	G;C;A	31;30;31	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	930	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1918	26.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
